TEXO Ventures

TEXO Ventures

TEXO Ventures launched in 2013 with an explicit geographic thesis: Austin, and Texas more broadly, harbored a density of healthcare talent and clinical infrastructure that did not match the venture dollars available locally. Jerry DeVries, a former McKinsey consultant with operating experience at a technology startup, partnered with Philip Edmondson-Jones to build a firm that would identify pre-seed and seed-stage companies and provide the first institutional capital many founders would receive. The firm's initial $20 million fund (per SEC filings, 2013) targeted digital health, healthcare services, and adjacent enterprise software, positioning TEXO as one of the few dedicated healthcare-tech investors in the Southwest at the time. TEXO's investment strategy centers on leading or co-leading rounds from pre-seed through Series A, with check sizes that allow the firm to build concentrated positions in a small number of portfolio companies each year. The partnership targets areas where regulatory shifts or payer dynamics create an opening for technology — historically this has included telemedicine platforms, provider-enablement tools, and insurance-technology businesses serving Medicare Advantage and commercial populations. Direct investments have included Admittance Health, a patient engagement and digital front-door platform, and Zenda Health, a benefits-navigation tool for employers. While anchored in Texas, the firm evaluates opportunities nationally when the founding team or customer base allows Texas-based pilots or clinical validation. TEXO also selectively participates in follow-on financings through its later funds, maintaining pro-rata in performing assets. The firm operates with a lean partnership structure out of Austin. Team size and total capital deployed have not been publicly disclosed beyond early fund filings, though SEC records indicate a second fund raised in 2016 and a third in 2019, suggesting steady, if quiet, deployment cadence. TEXO does not publicize a formal co-investor club, but its portfolio syndicates regularly include Austin-based angels, healthcare-focused micro-VCs, and occasionally larger multi-stage funds that enter at Series B. The firm has not disclosed affiliated philanthropic vehicles or operating companies beyond the core venture partnership. TEXO differs from most healthcare venture firms in its conviction that Texas's provider ecosystem — large integrated systems like Baylor Scott & White, Ascension Seton, and Houston Methodist — offers a built-in de-risking mechanism for early portfolio companies. By requiring founders to demonstrate clinical traction within these systems, TEXO compresses the diligence cycle that coastal investors must approximate through proxy metrics. This regional embeddedness functions as a sourcing moat and a structural differentiator, though it also bounds the firm's scale relative to generalist healthcare funds that invest across the US without local clinical-integration requirements.